- cafead   Jun 16, 2024 at 09:12: PM
via The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk (NOVOb.CO) CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices for weight loss drugs Ozempic and Wegovy.
article source
article source